Promoter holding
64.27%
WM
Walmark Meditech Private Limited - Due diligence report
A 360° intelligence report on Walmark Meditech: trust score, financial health, credit view, compliance, directors, growth and distress signa…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Walmark Meditech — 360° Intelligence Report
Generated from MCA filings & public records65/100
Trust Score
Moderate
Walmark Meditech is assessed as Moderate with a Trust Score of 65/100. Walmark Meditech is an active private limited indian non-government company incorporated in 2010, operating in the Chemicals sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 04 Jul 2026 from the latest processed filings. Walmark Meditech Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
65/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
20/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 60/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- Open charges exceed net worth - secured lenders rank ahead.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (D).
Charges position: 7 open (54.73 cr) · 1 satisfied (19.51 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Abhyudaya Co-Operative Bank Limited | 6 | 48.0 cr |
| Bank Of Baroda | 1 | 48.0 cr |
| Others | 1 | 48.0 cr |
Compliance Score: 20/100 Caution Indicated
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2021 - filings overdue.
- Flagged by authority: EPFO.
- Litigation present in 1 court forum(s).
- 1 auditor resignation(s) filed - latest: V S NASERY & COMPANY on 2015-06-12.
- Delayed payments to MSME suppliers disclosed (2 disclosure(s)).
- 2 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VILAS RAGHUNATH PAGE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SAROJ VILAS PAGE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAHUL VILAS PAGE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KUSHAL SANJAY KHOLAPURKAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 4 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2019)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2021 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Key managerial personnel: RAHUL VILAS PAGE (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 50 · Distress 55
Growth signals & trust indicators
Operating for 15+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Profit declined two years in a row.
Statutory filings appear overdue.
Compliance score is weak (20/100).
7 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 12.15 Lakh.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence44/100
Caution indicated
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 3 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment58/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 7 open charge(s) of 54.73 cr already registered.
- Compliance gaps should be priced into terms.
Investor view66/100
Mixed indicators
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Nov 2021
Last AGM held
Annual general meeting
31 Mar 2021
Latest balance sheet
Filed with ROC
28 Sep 2020
Charge created
Abhyudaya Co-Operative Bank Limited - 63.57 Lakh
17 Jul 2019
Charge created
Abhyudaya Co-Operative Bank Limited - 18.00 cr
09 Jul 2019
Charge satisfied
Bank Of Baroda
29 Jun 2019
Charge created
Abhyudaya Co-Operative Bank Limited - 12.00 cr
Charge created
Abhyudaya Co-Operative Bank Limited - 6.00 cr
16 Mar 2018
Securities allotted
50000 Debentures - 50.00 Lakh raised
Securities allotted
882352 Equity Shares - 4.50 cr raised
02 Aug 2016
Charge created
Others - 9.00 Lakh
30 Sep 2014
Director ceased
KUSHAL SANJAY KHOLAPURKAR
01 Mar 2014
Director appointed
KUSHAL SANJAY KHOLAPURKAR (Director)
31 Mar 2012
Charge created
Bank Of Baroda - 19.51 cr
04 Nov 2010
Incorporated
Registered with Roc Mumbai
Director appointed
VILAS RAGHUNATH PAGE (Director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - manageable leverage.
Net worth is positive.
4 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of D from Care.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2021 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Pegasus Farmaco | U24230TG1995PTC022036 | Andhra Pradesh, Telangana, India |
| Vikma Chemicals & Coatings Pvt Ltd | U24114WB1991PTC051065 | 24 Paraganas (South), West Bengal, India |
| Nithyasai Industries Limited | U24239AP2004PLC043277 | Visakhapatnam, Andhra Pradesh, India |
| Amchem Products Private Limited | U74899UP1993PTC117993 | Greater Noida, Uttar Pradesh, India |
| Apurva India Private Limited | U74999MH1995PTC090074 | Mumbai, Maharashtra, India |
| Glow Pharma Private Limited | U51900MH1993PTC074729 | Mumbai, Maharashtra, India |
| Krishnaraj Fertichem Private Limited | U24120GJ2012PTC071410 | Randheja, Gujarat, India |
| Skymap Healthcare Private Limited | U33116DL2003PTC316235 | New Delhi, Delhi, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Walmark Meditech before audits and certifications: compliance score 20/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Walmark Meditech: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Walmark Meditech - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Caution indicated. Trust score 65/100, distress signals and MSME payment-delay disclosures - know whether Walmark Meditech pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Walmark Meditech - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Walmark Meditech an active company?
Walmark Meditech has MCA status “Active” with a compliance score of 20/100 (Caution Indicated).
Is Walmark Meditech financially healthy?
Walmark Meditech has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.
Should I do business with Walmark Meditech?
Its overall Trust Score is 65/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Walmark Meditech?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.
Does Walmark Meditech have loans or charges against its assets?
7 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.
Is Walmark Meditech up to date with its ROC filings?
Last balance sheet is for Mar 2021 - filings overdue. Overall compliance score: 20/100 (Caution Indicated).
Is it risky to lend to Walmark Meditech?
Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
